Stage II Rectal Cancer AJCC V8

general

Stage III includes: IIIA: (T1-T2, N1/N1c, M0); (T1, N2a, M0); IIIB: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0); IIIC: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel t

65

Centers

102

Active Trials

$969M

Cancer Funding

Specific Cancer Types(2)

NameCenters
Stage IIA Rectal Cancer9
Stage IIC Rectal Cancer9

Top Centers for Stage II Rectal Cancer AJCC V8(65)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.6
2
High-Volume Research Center
72.6
3
NCI Comprehensive
Active Research Program
69.0
4
NCI Comprehensive
Active Research Program
69.0
5
NCI Comprehensive
Active Research Program
69.0
6
NCI Comprehensive
Active Research Program
69.0
7
NCI Comprehensive
Active Research Program
69.0
8
NCI Clinical
Active Research Program
69.0
9
NCI Comprehensive
Active Research Program
69.0
10
Active Research Program
69.0
11
NCI Comprehensive
Active Research Program
59.5
12
NCI Comprehensive
Active Research Program
59.5
13
NCI Comprehensive
Active Research Program
59.5
1459.5
15
NCI Comprehensive
Active Research Program
59.5
16
NCI Comprehensive
Active Research Program
59.5
17
NCI Comprehensive
Active Research Program
59.5
18
NCI Clinical
Active Research Program
59.5
19
NCI Comprehensive
Active Research Program
59.5
20
NCI Comprehensive
Active Research Program
59.5
21
NCI Comprehensive
Active Research Program
59.5
22
NCI Clinical
Active Research Program
59.5
23
Active Research Program
59.5
24
Active Research Program
59.5
25
Active Research Program
59.5
26
Active Research Program
59.5
27
Active Research Program
59.5
28
Active Research Program
59.5
29
NCI Comprehensive
Active Research Program
40.6
30
NCI Comprehensive
Active Research Program
40.6
31
NCI Comprehensive
Active Research Program
40.6
32
NCI Comprehensive
Active Research Program
40.6
33
NCI Comprehensive
Active Research Program
40.6
34
NCI Comprehensive
Active Research Program
40.6
35
NCI Comprehensive
Active Research Program
40.6
36
NCI Comprehensive
Active Research Program
40.6
37
NCI Comprehensive
Active Research Program
40.6
38
NCI Comprehensive
Active Research Program
40.6
39
NCI Comprehensive
Active Research Program
40.6
40
NCI Comprehensive
Active Research Program
40.6
41
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
40.6
42
NCI Comprehensive
Active Research Program
40.6
43
NCI Comprehensive
Active Research Program
40.6
44
NCI Comprehensive
Active Research Program
40.6
45
NCI Comprehensive
Active Research Program
40.6
46
NCI Comprehensive
Active Research Program
40.6
47
Active Research Program
40.6
48
Active Research Program
40.6
49
NCI Clinical
Active Research Program
40.6
50
Active Research Program
40.6
51
NCI Comprehensive
Active Research Program
40.6
52
NCI Comprehensive
Active Research Program
40.6
53
NCI Comprehensive
Active Research Program
40.6
54
Active Research Program
40.6
5540.6
56
Active Research Program
40.6
57
NCI Basic_laboratory
Active Research Program
40.6
58
Active Research Program
40.6
5940.6
60
Active Research Program
40.6
61
Active Research Program
40.6
62
Active Research Program
40.6
63
NCI Comprehensive
64
NCI Comprehensive
65
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →